References
- Xavier Castellsagué X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008; 110:S4–S7.
- Pimple S, Mishra G. Cancer cervix: Epidemiology and disease burden. Cytojournal. 2022;19:21.
- World Health Organization. Cervical cancer. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
- Chao A, Tsai Ch, Hsueh S. et. al. Does Epstein-Barr virus play a role in lymphoepithelioma-like carcinoma of the uterine cervix? Int J Gynecol Pathol. 2009;28:279–285.
- Vranic S, Cyprian FS, Akhtar S. et al. The Role of Epstein–Barr virus in Cervical Cancer: A Brief Update. Front Oncol. 2018;8:113.
- Cyprian FS, Al-Farsi H, Vranic S. et al. Epstein-Barr Virus and Human Papillomaviruses Interactions and Their Roles in the Initiation of Epithelial-Mesenchymal Transition and Cancer Progression. Front Oncol. 2018;8:111.
- Pereira de Lima MA, Neto PJN, Lima LM, et al. Association between Epstein-Barr virus (EBV) and cervical carcinoma: A meta-analysis. Gynecol Oncol. 2018:148:317–328.
- Oliviera LHS, Santos LS, Nogueira FG. Epstein Barr virus detection in cervical samples of women living with human immunodeficiency virus. Rev Inst Med Trop. 2011;53:231–234.
- Purtilo DT, Okano M and Grierson HL. Immune deficiency as a risk factor in Epstein-Barr virus-induced malignant diseases. Environ Health Perspect. 1990;88:225–230.
- Feng M, Duan R, Gao Y, et al. Role of Epstein-Barr Virus and Human Papillomavirus Coinfection in Cervical Intraepithelial Neoplasia in Chinese Women Living With HIV. Front Cell Infect Microbiol. 2021;11:703259.
- Hachisuga T, Ookuma Y, Fukuda K, et al. Detection of Epstein-Barr virus DNA from a lymphoma-like lesion of the uterine cervix. Gynecol Oncol. 1992;46:69–73.
- Hørding U, Daugaard, S, Bock JE. Human papillomavirus, Epstein-Barr virus, and cervical carcinoma in Greenland. Int J Gynecol Cancer. 1992;2:314–317.
- Ida K, Tokuda H, Kanaoka T. et al. Epstein-Barr virus activating principle in husbands’ semen of cervical cancer patients. Am J Reprod Immunol. 1991;26:89–92.
- Jezzoni JC, Gaffey MJ, Weiss LM. The Role of Epstein-Barr Virus in Lymphoepithelioma-like Carcinomas. Am J Clin Pathol. 1995;103:308–315.
- Saloua Kahla S, Oueslati S, Achour M. Correlation between EBV co-infection and HPV16 genome integrity in Tunisian cervical cancer patients. Braz J Microbiol. 2012;43:744–753.
- Khenchouche A, Sadouki N, Boudriche A. Human papillomavirus and Epstein-Barr virus co-infection in cervical carcinoma in Algerian women. Virol J. 2013;10:340.
- Kim NR, Lin Z, Kim KR. et al. Epstein-Barr virus and p16INK4A methylation in squamous cell carcinoma and precancerous lesions of the cervix uteri. J Korean Med Sci. 2005;20:636–642.
- Kitano Y, Fujisaki S, Nakamura N. et al. Immunological disorder against the Epstein-Barr virus infection and prognosis in patients with cervical carcinoma. Gynecol Oncol. 1995;57:150–157.
- Landers RJ, O’Leary JJ, Crowley M. et al. Epstein-Barr virus in normal, pre-malignant, and malignant lesions of the uterine cervix. J Clin Pathol. 1993;46:931–935.
- Prendiville W, Sankaranarayanan R. Colposcopy and Treatment of Cervical Precancer. Lyon (FR): International Agency for Research on Cancer; 2017.
- Valls J, Baena A, Venegas, G. et al. Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study. Lancet Glob Health. 2023;11:e350–60.
- Xue P, Ng MTA, Qiao Y. The challenges of colposcopy for cervical cancer screening in LMICs and solutions by artificial intelligence. BMC. 2020;169.
- Lanham S, Herbert A, Basarab A. et al. Detection of cervical infections in colposcopy clinic patients. J Clin Microbiol. 2001;39:2946–2950.